Innavasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular access for hemodialysis. The company’s first technology is an Arteriovenous Graft (AVG) modification that incorporates two cannulation pods, with low bleed technology, that are resistant to posterior and sidewall needle penetration and injury.

The Innavasc Arteriovenous Graft was designed to reduce the potential for adverse events and device failures associated with repeated vascular access.

Durham, NC, USA

InnAVasc Medical

Life Sciences

Delivers academic-driven research and education programs in the nexus of sustainability and business.

Duke University

Duke Capital Partners

Companies in the Duke Capital Partners portfolio are looking for talented, ambitious people to join their teams.

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Duke University Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Duke University network as they come up.

You can always update this information later.

Welcome to the Duke University talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Duke University company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Jobs at Portfolio Companies